Radiology of Bone Tumors Part 2 Dr P Tripathi

PrassanTripathi1 28 views 51 slides May 26, 2024
Slide 1
Slide 1 of 51
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51

About This Presentation

Medical education


Slide Content

Bone Tumours Dr Prassan Tripathi (MS) Assistant professor R.S.D.K.S.G.M.C. AMBIKAPUR Part-2

Osteosarcoma

Most common malignancy of the bone is SECONDARIES. Most common primary malignancy of the bone is MULTIPLE MYELOMA. SECOND MOST COMMON PRIMARY MALIGNANCY OF THE BONE IS OSTEOSARCOMA.

PROBLEM STATEMENT Accounts for 20% of primary malignancies of bone. Untreated it is highly lethal With surgery alone the 5 yr survival is 20% With the combined modalities of surgery and chemotherapy the 5 yr survival rate in many centers has touched as high as 75%

I ncidence- higher in males M:F ratio is 3:2 Locations - All skeletal locations can be affected; THE LOCATION IS ALMOST ALWAYS METAPHYSIS Primary osteosarcomas occur at the sites of the most rapid bone growth- THE DISTAL FEMUR, THE PROXIMAL TIBIA PROXIMAL HUMERUS.

CLASSIFICATION (ON THE BASIS OF CLINICAL SETTING) TWO TYPES :- PRIMARY OCCURS IN 15-25 YEARS OF AGE PROPER ETIOLOGY UNKNOWN SECONDARY OCCURS AFTER 40-45 YEARS OF AGE UNCOMMON Associated with PREMALIGNANT CONDITIONS Eg : PAGETS DISEASE, MULTIPLE ENCHONDROMATOSIS, OSTEOCHONDROMAS, FIBROUS DYSPLASIA

CLASSIFICATION OSTEOBLASTIC-OSTEOBLASTS PREDOMINATE CHONDROID TYPE-CHONDRBLASTS PREDOMINATE FIBROBLASTIC-FIBROBLASTS PREDOMINATE OSTEOLYLIC OR TELANGIECTATIC (WORST PROGNOSIS) (on the basis of histopathology)

ALL OSTEOSARCOMAS ARE MALIGNANT AND METASTASIS OCCURS VIA THE HAEMATOGENOUS ROUTE –BLOOD STREAM REMEMBER SARCOMAS LYPHATIC SPREAD IS UNCOMMON ALMOST ALWAYS THE FIRST METASTASIS IS TO LUNGS

PATHOLOGY MALIGNANT TUMOUR OF MESENCHYMAL CELLS CHARACTERISED BY BONE FORMATION / OSTEOID FORMATION BY MALIGNANT CELLS

GROSS APPEARANCE GROSS APPEARANCE IS OF VIVID TYPES DEPENDING UPON THE TYPE OF OSTEOSARCOMA THE CONVENTIONAL OSTEOBLASTIC TYPE TYPICALLY IS GREYISH WHITE,HARD AND HAS A GRITTY FEELING WHEN CUT. MOST TUMOURS HAVE MIXED AREAS OF BONE FORMATION AND CYSTIC SPACES.

Gross specimen Resected Osteosarcoma Osteosarcoma of the distal femur shows irregular expansion of bone by a sclerotic mass with erosion of the cortex and extension into soft tissue

HISTOPATHOLOGY HISTOLOGICALLY CHARACTERISED BY “MALIGNANT MESENCHYMAL SPINDLE SHAPED CELLS SURROUNDING THE OSTEOID”

Histology of Osteosarcoma-Osteoid deposition

CLINICAL FEATURES PAIN – 1 ST SYMPTOM SOON FOLLOWED BY SWELLING HISTORY OF TRAUMA IS ALMOST ALWAYS PRESENT ONLY INCIDENTAL TAKES PATIENTS ATTENTION TOWARDS THE SWELLING. PATHOLOGICAL FRACTURE LOCAL INVASION-NEUROVASCULAR DAMAGE FUNGATING MASS

SEVERE SWELLING IN THIGH-PATIENT HAD PRESENTED WITH A PATHOLOGICAL FRACTURE

CUT SECTION THROUGH THE TUMOUR

EXAMINATION SWELLING – IN THE METAPHYSIS SKIN OVERLYING IS SHINY WITH PROMINENT VEINS ILL DEFINED MARGING MOVEMENTS RESTRICTED DUE TO SIZE OF THE TUMOUR REMEMBER THE TUMOUR NEVER CROSSED THE EPIPHYSEAL PLATE

INVESTIGATIONS:- 1. X-RAY-1 ST INVESTIGATION 2. MRI-GIVES INFORMATION ABOUT THE EXTENT OF TUMOUR AND SOFT TISSUE AND BONY INVOLVEMENT 3.BIOPSY-GOLD STANDARD IN DIAGNOSIS OF BONE TUMOURS/HIGHEST SENSITIVITY AND SPECIFICITY HRCT CHEST-FOR SECONDARIES/METS

X-RAYS IRREGULAR BONY DESTRUCTION IN THE METAPHYSIS NEWBONE FORMATION IRREGULAR PERIOSTEAL REACTION CODMANS TRIANGLE SUNRAY APPEARNCE

IRREGULAR BONY DESTRUCTION WITH NEW BONE FORMATION

CODMANS TRIANGLE-SUBPERIOSTEAL NEW BONE FORMATION

Sunburst appearnce

BLOOD INVESTIGATIONS SERUM ALKALINE PHOSPHATASE LEVELS:- BONE FORMING TUMOUR -HIGH LEVELS OF SERUM ALKALINE PHOSPHATASE LEVELS PROGNOSTIC IMPORTANCE /NOT DIAGNOSTIC LEVELS FALL AFTER AMPUTATION LEVELS RISE BACK IN RELAPSE/STUMP CARCINOMA

TREATMENT DESPITE ALL TREATMENT –VERY POOR PROGNOSIS VERY LOW 5 YEAR SURVIVAL RATE

BEST TREATMENT IS RADICAL AMPUTATION-AMPUTATION AT A LEVEL ONE JOINT ABOVE THE LESION EG ABOVE KNEE AMPUTATION FOR A TUMOUR OF TIBIA HOWEVER WITH CHEMOTHERAPY SOME RECOMMEND A SAFE MARGIN OF 10 CM FOR RESECTION. RADIOTHERAPY HAS ABSOLUTELY NO ROLE AS THE TUMOUR IS RADIORESISTANT.IS RESERVED FOR PATIENTS REFUSING SURGERY OR TUMOUR AT INACCESSIBLE SITES

CURRENT PROTOCOL IS : NEO ADJUVANT CHEMOTHERAPY FOLLOWED BY AMPUTATION/WIDE RESECTION FOLLOWED BY ADJUVANT CHEMOTHERAPY

CHEMOTHERAPY USES METHOTREXATE WITH CITROVORUM FACTOR(FOLINIC ACID) CISPLATIN ENDOXAN

SECONDARIES ARE TREATED BY CHEMOTHERAPY SOLITARY LUNG METASTASIS CAN BE RESECTED OUT.

SECONDARY OSTEOSARCOMA OCCURS IN PREMALIGNANT STATES:- PAGETS DISEASE DIAPHYSIAL ACHLASIA OSTEOCHONDROMA FIBROUS DYSPLASIA MULTIPLE ENCHONDROMATOSIS POST IRRADIATION

EWING SARCOMA

UNDIFFERENTIATED PRIMITIVE NEUROECTODERMAL TUMOUR (P-NET FAMILY) DIAPHYSEAL TUMOUR-***ALMOST ALWAYS OCCURS IN DIAPHYSIS

Highly malignant tumour Found in young age 5-15 years of age More commonly male population is affected

PATHOLOGY MOST COMMONLY OCCURS IN DIAPHYSIS OF FEMUR FOLLOWED BY FIBULA AND THEN ILEUM AND THEN TIBIA. IN ONE THIRD CASES IT MAY ALSO OCCUR IN FLAT BONES USUALLY PELVIS AND THE CALCANEUM

COMMON CYTOGENIC ABNORMALITY:- ****CYTOGENIC TRANSLOCATION OF CHROMOSOMES 11 AND 22 t(11:22) seen in 85-90 % of cases. Followed by t(21:22) followed by t(7:22)

PATHOLOGY Tumour characteristically involves a large area almost all of the Medullary Cavity. The tumour is grey white, soft and thin almost like pus. The bone expanded and periosteum elevated with the new bone formation occuring in layers giving rise to the onion peel appearance which is the characteristic radiological feature . The tumour ruptures from the cortex and extends into the soft tissues.

histopathology Histopathology is characteristic Consists of sheets of uniform lymphocyte like round cells. Sometimes these cells surround a central clear area forming a pseudo-rosette. *** round neural cells containing glycogen and reticulin which are PAS positive and diastase digestible.

Histological picture of ewing sarcoma

Clinical features This is one malignancy which is associated with systemic symptoms**** such as weight loss ,fever,raised ESR and anemia. Lab abnormalities like leukocytosis,raised LDH and ESR may be present. And others signs and symptoms are like with other tumours PAIN SWELLING TENDERNESS PATHOLOGICAL FRACTURE RESTRICTED JOINT MOVEMENTS NEUROVASCULAR COMPRESSION

INVESTIGATIONS 1. X ray 2. MRI 3.Biopsy 4.HRCT chest for metastasis

Extremely poor prognosis *** Bone to Bone metastasis is seen Most common metastsis is to the lung Micrometastasis is almost always there at the time of diagnosis.

Radiological finding mottled rarefaction of the bone with permeation of the overlying cortex indicating rapid bone destruction Soft tissue mass Lamellated periosteal reaction with new bone formation known as onion peel appearance

Ewing sarcoma of the radius

TREATMENT The tumour is highly radiosensitive and chemosensitive It is said it melts like snow on radiotherapy However it will always recur. Chemotherapy includes Vincristine,Adriamycin and Cyclophosphamide.

Treatment Neoadjuvant chemotherapy Followed by Amputation Followed by adjuvant chemotherapy/radiotherapy.

THANK YOU!

STAGING OF BONE TUMOURS